Lab Manager Position

2010-09-26

The group of Joan Seoane within the Vall d’Hebron Institute of Oncology, Barcelona, is looking for a lab manager fellow.  Our main field of interest is the understanding of the molecular mechanisms involved in the genesis and progression of glioma. Glioma is the most common and aggressive tumour of the brain and its most malignant form, glioblastoma multiforme, is nowadays virtually not curable. Very little is known about glioma genesis and progression at the molecular level and not much progress has been achieved in the treatment of this disease during the last years. The understanding of the molecular mechanisms involved in the biology of glioma is essential for the development of successful and rational therapeutic strategies. Our approach is based on a tight collaboration with clinical researchers of the Vall d’Hebron hospital and the study of patient-derived tumours. We analyse human biopsies, generate primary cultures of human tumour cells, isolate the stem-cell-like population of patient-derived gliomas and generate mouse models for glioma based on the orthotopical inoculation of human glioma stem cells in the mouse brain to generate tumours with the same characteristics as the original human tumour. Moreover, we participate in ongoing clinical trials obtaining critical information about the biology of human tumours. We expect that our results will help understand the biology of glioma and cancer, and we aspire to translate our discoveries to a clinical ambit identifying molecular markers of diagnosis and prognosis, markers of response to therapies, and unveil new therapeutic targets against this deadly disease.

Post-Doctoral Position

2010-09-26

The group of Joan Seoane within the Vall d’Hebron Institute of Oncology, Barcelona, is looking for a post-doctoral research fellow.  Our main field of interest is the understanding of the molecular mechanisms involved in the genesis and progression of glioma. Glioma is the most common and aggressive tumour of the brain and its most malignant form, glioblastoma multiforme, is nowadays virtually not curable. Very little is known about glioma genesis and progression at the molecular level and not much progress has been achieved in the treatment of this disease during the last years. The understanding of the molecular mechanisms involved in the biology of glioma is essential for the development of successful and rational therapeutic strategies. Our approach is based on a tight collaboration with clinical researchers of the Vall d’Hebron hospital and the study of patient-derived tumours. We analyse human biopsies, generate primary cultures of human tumour cells, isolate the stem-cell-like population of patient-derived gliomas and generate mouse models for glioma based on the orthotopical inoculation of human glioma stem cells in the mouse brain to generate tumours with the same characteristics as the original human tumour. Moreover, we participate in ongoing clinical trials obtaining critical information about the biology of human tumours. We expect that our results will help understand the biology of glioma and cancer, and we aspire to translate our discoveries to a clinical ambit identifying molecular markers of diagnosis and prognosis, markers of response to therapies, and unveil new therapeutic targets against this deadly disease.

Técnico/a de Laboratorio (proceso cerrado)

2010-04-02

Gestores de datos en ensayos clínicos de oncologia (proceso cerrado)

2010-03-16

Ofrecemos 3 plazas de gestores de datos en Ensayos Clínicos de Oncología

Administrativo/a contable (proceso cerrado)

2010-03-03

Se incorporará a VHIO para dar apoyo al Departamento Económico-Financiero de la Fundación.

Administrativo/a de compras

2010-03-03

Se incorporará a VHIO para dar apoyo al Departamento Económico-Financiero de la Fundación. 

Responsable de Servicios Generales (proceso cerrado)

2010-01-30

Dependiendo de la Gerencia de la Fundación, sus tareas serán las de gestionar las infraestructuras, instalaciones, equipamientos y servicios generales con el objetivo de garantizar unas óptimas condiciones de funcionalidad y seguridad en los espacios vinculados a VHIO.

Técnico para el Servicio de Genómica (proceso cerrado)

2009-12-15

La investigación en genómica es clave para la caracterización de los tumores, y tendrá un papel relevante en la investigación básica y clínica del el futuro, así como en el desarrollo de fármacos contra el cáncer.

El Técnico para el Servicio de Genómica del VHIO proporcionará genotipado (secuenciación con tecnología MassARRAY) y secuenciación de alto rendimiento (Genome Analyzer II, Illumina) a los investigadores básicos y clínicos del Instituto. Además, apoyaremos a los investigadores con análisis bioinformático, personalizado para cada proyecto individual.

Grants manager (proceso cerrado)

2009-08-20

Responsable de subvenciones

Posiciones abiertas para estudiantes de Doctorado y Post-Doctorado

2009-08-20

El Laboratorio de Modelos Animales y Cáncer del Institut de Recerca Vall d'Hebron ofrece varios puestos para la investigación en melanoma y oncología translacional

CURRICULUM

Los campos marcados con * son obligatorios